Benzamide

Benzamide

SCHEMBL2841981

NC(=O)c1ccccc1.Nc1nccs1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.57
TSHR P16473 2/20 0.57
POLB P06746 1/20 0.57
CYP3A4 P08684 1/20 0.57
PARP1 P09874 1/20 0.57
MAPT P10636 1/20 0.57
CYP2C19 P33261 1/20 0.57
RECQL P46063 1/20 0.57
BLM P54132 1/20 0.57
PMP22 Q01453 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
ALDH1A1 P00352 4/20 0.54
NOS1 P29475 1/20 0.54
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
KDM4B O94953 1/20 0.46
KDM5C P41229 1/20 0.46
KDM5B Q9UGL1 1/20 0.46
MEN1 O00255 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzamide SCHEMBL3177602 0.84 PARP1 (0.55) HSD17B10TSHRPOLBCYP3A4PARP1
Benzamide SCHEMBL4367079 0.83 HSD17B10 (0.53) HSD17B10TSHRPOLBCYP3A4PARP1
2-Phenylthiazole SCHEMBL5968560 0.81 PDPK1 (0.68) HSD17B10TSHRPOLBCYP3A4PARP1
Aminothiazole SCHEMBL1241596 0.80 ALDH1A1 (0.75) HSD17B10TSHRMAPTRECQLL3MBTL1
Benzamide SCHEMBL27660453 0.78 PARP1 (0.94) HSD17B10TSHRPOLBCYP3A4PARP1
Aminothiazole SCHEMBL6051173 0.78 ALDH1A1 (0.88) HSD17B10TSHRCYP3A4CYP2C19BLM
Aminothiazole SCHEMBL27899272 0.78
Biphenyl SCHEMBL28794521 0.77 ALDH1A1 (0.68) HSD17B10TSHRCYP3A4MAPTTDP1
Aminothiazole SCHEMBL1003511 0.77 ALDH1A1 (0.68) HSD17B10TSHRMAPTRECQLL3MBTL1
Aminothiazole SCHEMBL4466019 0.77 ALDH1A1 (0.68) HSD17B10TSHRMAPTRECQLL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017066225-A1 PHARMACOPERONES OF THE V2 RECEPTOR TEXAS TECH UNIVERSITY SYSTEM (US) 2017-04-20 WO claimed
CN-109320473-A Thiazoleamino benzamide acetogenin and application thereof 南华大学 2019-02-12 CN disclosed
CN-109320473-A Thiazoleamino benzamide acetogenin and application thereof 南华大学 2019-02-12 CN disclosed
CN-109320473-A Thiazoleamino benzamide acetogenin and application thereof 南华大学 2019-02-12 CN disclosed
WO-2017066225-A1 PHARMACOPERONES OF THE V2 RECEPTOR TEXAS TECH UNIVERSITY SYSTEM (US) 2017-04-20 WO disclosed
US-20140179711-A1 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-06-26 US disclosed
US-8680103-B2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-03-25 US disclosed
EP-1711481-B2 CRYSTALLINE MONOHYDRATE AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2013-05-22 EP disclosed
US-20120302750-A1 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-11-29 US disclosed
US-8242270-B2 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2012-08-14 US disclosed
EP-1594866-A1 ANTIPROLIFERATIVE 2-(SULFO-PHENYL)-AMINOTHIAZOLE DERIVATIVES PFIZER INC. (US) 2005-11-16 EP disclosed
US-20050215795-A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2005-09-29 US disclosed
WO-2005077945-A2 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-08-25 WO disclosed
WO-2005076990-A2 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-CARBOXAMIDES USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-08-25 WO disclosed
US-20050176965-A1 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2005-08-11 US disclosed
US-20050176773-A1 Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and method for their use AGOURON PHARMACEUTICALS, INC. 2005-08-11 US disclosed
US-20050038078-A1 Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and methods for their use AGOURON PHARMACEUTICALS, INC. 2005-02-17 US disclosed
US-20040176431-A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use PFIZER, INC. 2004-09-09 US disclosed
WO-2004072070-A1 ANTIPROLIFERATIVE 2-(SULFO-PHENYL)-AMINOTHIAZOLE DERIVATIVES PFIZER INC. (US) 2004-08-26 WO disclosed
WO-2004014904-A1 ANTIPROLIFERATIVE 2-(HETEROARYL)-AMINOTHIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE PFIZER INC. (US) 2004-02-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120302750-A1 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS MAP3K5, MAP3K2, MAP3K20 HSD17B10 2868/4885TSHR 995/4885POLB 4131/4885
US-20050215795-A1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors MAP3K5, MAP3K2, MAP3K20 HSD17B10 2868/4885TSHR 995/4885POLB 4131/4885
US-20050176773-A1 Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and method for their use CDK2, MKI67, CCNK HSD17B10 2047/4885TSHR 3589/4885POLB 749/4885
US-20050176965-A1 Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors CDK2, MAP3K5, MAP4K2 HSD17B10 3846/4885TSHR 1144/4885POLB 3235/4885
US-20050038078-A1 Antiproliferative 2-(heteroaryl)-aminothiazole compounds and pharmaceutical compositions, and methods for their use CDK2, CCNK, MKI67 HSD17B10 2277/4885TSHR 3823/4885POLB 885/4885
US-20140179711-A1 PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS MAP3K5, MAP3K2, MAP3K20 HSD17B10 2868/4885TSHR 995/4885POLB 4131/4885
US-20040176431-A1 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use MKI67, TK1, CDK2 HSD17B10 2308/4885TSHR 2697/4885POLB 1792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.